The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer1Presented at the 13th Asia Pacific Cancer Conference, Penang, Malaysia, November 17–20, 1996 and also presented at the Royal Australasian College of Radiologists 47th Annual General and Scientific Meeting, Perth, Western Australia, October 5–9th, 1996. Accepted for presentation at the American Radium Society 79th Annual Meeting, New York, N.Y., April 30–May 4, 1997.1